NasdaqCM - Nasdaq Real Time Price • USD
DarioHealth Corp. (DRIO)
As of 12:35 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 2 |
| Avg. Estimate | -0.4 | -0.41 | -1.37 | -0.87 |
| Low Estimate | -0.59 | -0.58 | -2.2 | -1.61 |
| High Estimate | -0.22 | -0.25 | -0.83 | -0.14 |
| Year Ago EPS | -0.45 | -0.58 | -1.93 | -1.37 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 2 |
| Avg. Estimate | 6.76M | 9.42M | 37.33M | 49.7M |
| Low Estimate | 5.95M | 8.1M | 32.79M | 41.37M |
| High Estimate | 7.57M | 10.74M | 41.61M | 58.03M |
| Year Ago Sales | 6.7M | 6.46M | 20.35M | 37.33M |
| Sales Growth (year/est) | 0.90% | 45.80% | 83.40% | 33.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.52 | -0.46 | -0.55 |
| EPS Actual | -0.45 | -0.58 | -0.49 | -0.5 |
| Difference | 0.05 | -0.06 | -0.03 | 0.05 |
| Surprise % | 10.00% | -11.50% | -6.50% | 9.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.4 | -0.41 | -1.37 | -0.87 |
| 7 Days Ago | -0.4 | -0.41 | -1.51 | -0.87 |
| 30 Days Ago | -0.45 | -0.34 | -1.55 | -1.61 |
| 60 Days Ago | -0.45 | -0.34 | -1.77 | -1.61 |
| 90 Days Ago | -0.5 | -0.47 | -1.73 | -1.52 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | DRIO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 11.10% | -- | -- | 1.50% |
| Next Qtr. | 29.30% | -- | -- | 12.10% |
| Current Year | 29.00% | -- | -- | 4.40% |
| Next Year | 36.50% | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 4/1/2024 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/11/2023 |
| Maintains | Stifel: Buy to Buy | 7/25/2023 |
| Maintains | Craig-Hallum: Buy to Buy | 5/12/2023 |
| Maintains | Alliance Global Partners: Buy | 11/16/2022 |
| Maintains | Aegis Capital: Buy | 8/18/2022 |
Related Tickers
ACRS Aclaris Therapeutics, Inc.
1.1800
-0.84%
PRPH ProPhase Labs, Inc.
4.8150
-2.73%
MDXH MDxHealth SA
2.4600
-0.40%
NOTV Inotiv, Inc.
4.0400
-5.83%
NEO NeoGenomics, Inc.
14.30
+3.25%
PMD Psychemedics Corporation
2.5500
-2.67%
BDSX Biodesix, Inc.
1.2300
-2.38%
AWH Aspira Women's Health Inc.
3.3500
+2.13%
TRIB Trinity Biotech plc
1.8400
+0.55%
STIM Neuronetics, Inc.
3.4750
-1.28%